Proteomic analysis of plasma from children with sickle cell anemia and silent cerebral infarction
Proteomic analysis of plasma from children with sickle cell anemia and silent cerebral infarction
Silent cerebral infarction is the commonest neurological abnormality in children with sickle cell anemia, affecting 30-40% 14 year olds. There are no known biomarkers to identify children with silent cerebral infarcts and the pathological basis is also unknown. We used an unbiased proteomic discovery approach to identify plasma proteins differing in concentration between children with and without silent cerebral infarcts. Clinical parameters and plasma samples were analysed from 51 children (mean age 11.8 years, range 6-18) with sickle cell anemia (HbSS). 19 children had silent cerebral infarcts and 32 normal MRI; the children with silent infarcts had lower HbF levels (8.6 vs. 16.1%, P=0.049) and higher systolic blood pressures (115 vs 108.6, P=0.027). Plasma proteomic analysis showed 13 proteins increased more than 1.3 fold in the SCI patients, including proteins involved in hypercoagulability (α2-antiplasmin, fibrinogen-γ chain, thrombospondin-4), inflammation (α2-macroglobulin, complement C1s and C3) and atherosclerosis (apolipoprotein B-100). Higher levels of gelsolin and retinol-binding protein 4 were also found in the population with silent infarcts, both of which have been linked to stroke. We investigated the genetic basis of these differences by studying 359 adults with sickle cell disease (199 with silent cerebral infarcts, 160 normal MRIs), who had previously undergone a genome-wide genotyping array. None of the genes coding for the differentially expressed proteins were significantly associated with silent infarction. Our study suggests that silent cerebral infarcts in sickle cell anemia may be associated with higher systolic blood pressure, lower HbF levels, hypercoagulability, inflammation and atherosclerotic lipoproteins.
Journal Article
Tewari, Sanjay
4275b302-c0a7-435d-8bd2-734ee3743c8e
Renney, George
9ffd87a7-cbb4-4c1f-a987-b8e2f470d70d
Brewin, John
1ad9a4fe-0964-4621-b8c7-0c7829b0000d
Gardner, Kate
6f9ef6d4-96b5-4374-92ab-d86fbc8531b4
Kirkham, Fenella
1dfbc0d5-aebe-4439-9fb2-dac6503bcd58
Inusa, Baba
830cfc6c-2482-4986-b2d3-9edd5cf2d9f5
Barrett, James E
0c1252a5-3836-4b96-af69-1dd4a1edf79b
Menzel, Stephan
5c8f3f55-d218-4f7f-8ef2-0fd0ea13d44c
Thein, Swee Lay
496d02c6-084c-4778-ba43-abbcc667e0da
Ward, Malcolm
9a99f0da-f27e-423e-ae11-3544de614c2d
Rees, David C
8edfda69-3e13-4e7a-83b9-6bb2784f1968
Tewari, Sanjay
4275b302-c0a7-435d-8bd2-734ee3743c8e
Renney, George
9ffd87a7-cbb4-4c1f-a987-b8e2f470d70d
Brewin, John
1ad9a4fe-0964-4621-b8c7-0c7829b0000d
Gardner, Kate
6f9ef6d4-96b5-4374-92ab-d86fbc8531b4
Kirkham, Fenella
1dfbc0d5-aebe-4439-9fb2-dac6503bcd58
Inusa, Baba
830cfc6c-2482-4986-b2d3-9edd5cf2d9f5
Barrett, James E
0c1252a5-3836-4b96-af69-1dd4a1edf79b
Menzel, Stephan
5c8f3f55-d218-4f7f-8ef2-0fd0ea13d44c
Thein, Swee Lay
496d02c6-084c-4778-ba43-abbcc667e0da
Ward, Malcolm
9a99f0da-f27e-423e-ae11-3544de614c2d
Rees, David C
8edfda69-3e13-4e7a-83b9-6bb2784f1968
Tewari, Sanjay, Renney, George, Brewin, John, Gardner, Kate, Kirkham, Fenella, Inusa, Baba, Barrett, James E, Menzel, Stephan, Thein, Swee Lay, Ward, Malcolm and Rees, David C
(2018)
Proteomic analysis of plasma from children with sickle cell anemia and silent cerebral infarction.
Haematologica, 103 (4).
(doi:10.3324/haematol.2018.187815).
Abstract
Silent cerebral infarction is the commonest neurological abnormality in children with sickle cell anemia, affecting 30-40% 14 year olds. There are no known biomarkers to identify children with silent cerebral infarcts and the pathological basis is also unknown. We used an unbiased proteomic discovery approach to identify plasma proteins differing in concentration between children with and without silent cerebral infarcts. Clinical parameters and plasma samples were analysed from 51 children (mean age 11.8 years, range 6-18) with sickle cell anemia (HbSS). 19 children had silent cerebral infarcts and 32 normal MRI; the children with silent infarcts had lower HbF levels (8.6 vs. 16.1%, P=0.049) and higher systolic blood pressures (115 vs 108.6, P=0.027). Plasma proteomic analysis showed 13 proteins increased more than 1.3 fold in the SCI patients, including proteins involved in hypercoagulability (α2-antiplasmin, fibrinogen-γ chain, thrombospondin-4), inflammation (α2-macroglobulin, complement C1s and C3) and atherosclerosis (apolipoprotein B-100). Higher levels of gelsolin and retinol-binding protein 4 were also found in the population with silent infarcts, both of which have been linked to stroke. We investigated the genetic basis of these differences by studying 359 adults with sickle cell disease (199 with silent cerebral infarcts, 160 normal MRIs), who had previously undergone a genome-wide genotyping array. None of the genes coding for the differentially expressed proteins were significantly associated with silent infarction. Our study suggests that silent cerebral infarcts in sickle cell anemia may be associated with higher systolic blood pressure, lower HbF levels, hypercoagulability, inflammation and atherosclerotic lipoproteins.
Text
haematol.2018.187815.full
- Accepted Manuscript
More information
Accepted/In Press date: 14 March 2018
e-pub ahead of print date: 15 March 2018
Keywords:
Journal Article
Identifiers
Local EPrints ID: 419546
URI: http://eprints.soton.ac.uk/id/eprint/419546
ISSN: 0390-6078
PURE UUID: 3259c569-9bbe-4db5-aceb-00bea3c6298c
Catalogue record
Date deposited: 13 Apr 2018 16:30
Last modified: 16 Mar 2024 03:22
Export record
Altmetrics
Contributors
Author:
Sanjay Tewari
Author:
George Renney
Author:
John Brewin
Author:
Kate Gardner
Author:
Baba Inusa
Author:
James E Barrett
Author:
Stephan Menzel
Author:
Swee Lay Thein
Author:
Malcolm Ward
Author:
David C Rees
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics